Boston Scientific Gains Neuro, Cardiovascular Access Devices Via Acquisition
This article was originally published in The Gray Sheet
Executive SummaryMicrofabricated guidewires to facilitate interventional cardiology procedures will be developed by Boston Scientific, following the purchase of Precision Vascular Systems, Inc
You may also be interested in...
Keytruda is set to remain dominant despite knockback, though Tecentriq could claim prized NSCLC adjuvant approval first